Thymosin Alpha-1· 10mg
28-amino-acid thymic peptide. Immune modulation and antiviral research.
Individual
$142.20
label.overview
Synthetic version of the natural thymic peptide. Used clinically (Zadaxin) for hepatitis B and immune restoration in oncology.
Thymosin Alpha-1 enhances T-cell differentiation and natural-killer cell activity. Approved in over 30 countries for chronic hepatitis B and adjuvant cancer therapy.
Mechanism
TLR signaling; T-cell maturation.
Researcher notes
- • 1.6 mg subcutaneous, twice weekly.
- • Cycle: 8–12 weeks.
Mechanism
TLR signaling; T-cell maturation.
Half-life
~2 hours
Reconstitution
Add 2 mL bacteriostatic water to the 10 mg vial. Each 0.32 mL = 1.6 mg.
Storage
Lyophilized: 2–8 °C. Reconstituted: 2–8 °C, use within 30 days.
Reconstitution & general research dosing
- Reconstitution
- 5 mL bacteriostatic water into a 10 mg vial → 2 mg/mL (each 0.8 mL = 1.6 mg).
- Typical research dose
- Clinical reference 1.6 mg twice weekly.
- Frequency
- Twice weekly, subcutaneous.
- Vial duration
- A 10 mg vial covers ~3 weeks at 1.6 mg twice weekly (3.2 mg/week) — inside the 30-day reconstituted-use window.
- Storage
- Refrigerate 2–8 °C; use within 30 days reconstituted.